Anti-programmed cell death protein 1 (anti-PD-1) and anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA-4) monoclonal antibodies (mAbs) have revolutionized anticancer treatment. However, there are still many patients who do not respond or acquire resistance to these treatments. Learn more about Immune Checkpoint Small Molecule Drug: https://immune-checkpoint.crea....tive-biolabs.com/imm
Gusto
Magkomento
Ibahagi
